-+ 0.00%
-+ 0.00%
-+ 0.00%

GENMAB ANNOUNCES RINATABART SESUTECAN (RINA-S®) DEMONSTRATES STATISTICALLY SIGNIFICANT IMPROVEMENT IN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER

Reuters·10/23/2026 15:56:05